Treatment of diffuse large B-cell lymphoma.

摘要: A review of new or emerging ideas concerning diffuse large B-cell lymphomas (DLBCL) is presented with particular emphasis on histologic classification, genetic prognostic factors, and first-line treatments. This lymphoma rests the most heterogeneous all for its clinical characteristics outcome. heterogeneity probably secondary to fact that a proportion seems occur from transformation an unknown indolent lymphoma. Current treatment based combination chemotherapy including cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) dose-intense CHOP-like regimen, rituximab (R-CHOP).